Filtronic plc (FLTCF)
OTCMKTS · Delayed Price · Currency is USD
1.970
-0.060 (-2.96%)
At close: Jul 31, 2025
Verve Therapeutics Income Statement
Financials in millions GBP. Fiscal year is June - May.
Millions GBP. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
| 56.32 | 25.43 | 16.27 | 17.05 | 15.56 | Upgrade | |
Revenue Growth (YoY) | 121.45% | 56.33% | -4.60% | 9.62% | -9.46% | Upgrade |
Cost of Revenue | - | 9.36 | 5.99 | 5.65 | 5.46 | Upgrade |
Gross Profit | 56.32 | 16.08 | 10.28 | 11.41 | 10.09 | Upgrade |
Selling, General & Admin | - | 8.18 | 6.86 | 6.42 | 6.32 | Upgrade |
Other Operating Expenses | 39.31 | 3.05 | 2.15 | 2.18 | 2 | Upgrade |
Operating Expenses | 41.57 | 12.47 | 10.04 | 9.82 | 9.47 | Upgrade |
Operating Income | 14.75 | 3.61 | 0.24 | 1.58 | 0.62 | Upgrade |
Interest Expense | -0.27 | -0.24 | -0.14 | -0.13 | -0.14 | Upgrade |
Interest & Investment Income | 0.16 | 0.08 | 0.01 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.05 | 0 | 0.05 | 0.11 | -0.21 | Upgrade |
Other Non Operating Income (Expenses) | -1.3 | -0.1 | -0.09 | -0.07 | -0.08 | Upgrade |
EBT Excluding Unusual Items | 13.39 | 3.36 | 0.06 | 1.5 | 0.19 | Upgrade |
Asset Writedown | - | - | - | - | -0.05 | Upgrade |
Other Unusual Items | - | - | - | 0.39 | 0.06 | Upgrade |
Pretax Income | 13.39 | 3.36 | 0.06 | 1.89 | 0.21 | Upgrade |
Income Tax Expense | -0.66 | 0.22 | -0.4 | 0.42 | 0.15 | Upgrade |
Earnings From Continuing Operations | 14.05 | 3.14 | 0.46 | 1.47 | 0.06 | Upgrade |
Net Income | 14.05 | 3.14 | 0.46 | 1.47 | 0.06 | Upgrade |
Net Income to Common | 14.05 | 3.14 | 0.46 | 1.47 | 0.06 | Upgrade |
Net Income Growth | 347.28% | 576.94% | -68.39% | 2346.67% | - | Upgrade |
Shares Outstanding (Basic) | 219 | 216 | 215 | 215 | 213 | Upgrade |
Shares Outstanding (Diluted) | 232 | 223 | 216 | 216 | 214 | Upgrade |
Shares Change (YoY) | 4.19% | 2.96% | 0.41% | 0.61% | 1.55% | Upgrade |
EPS (Basic) | 0.06 | 0.01 | 0.00 | 0.01 | 0.00 | Upgrade |
EPS (Diluted) | 0.06 | 0.01 | 0.00 | 0.01 | 0.00 | Upgrade |
EPS Growth | 329.08% | 571.43% | -69.11% | 2319.57% | - | Upgrade |
Free Cash Flow | 10.01 | 5.66 | 0 | 2.22 | 2.28 | Upgrade |
Free Cash Flow Per Share | 0.04 | 0.03 | - | 0.01 | 0.01 | Upgrade |
Gross Margin | 100.00% | 63.21% | 63.17% | 66.90% | 64.89% | Upgrade |
Operating Margin | 26.18% | 14.19% | 1.46% | 9.29% | 4.00% | Upgrade |
Profit Margin | 24.95% | 12.35% | 2.85% | 8.61% | 0.39% | Upgrade |
Free Cash Flow Margin | 17.77% | 22.26% | 0.03% | 13.04% | 14.65% | Upgrade |
EBITDA | 16.16 | 3.83 | 0.44 | 1.97 | 0.89 | Upgrade |
EBITDA Margin | 28.69% | 15.05% | 2.70% | 11.53% | 5.70% | Upgrade |
D&A For EBITDA | 1.41 | 0.22 | 0.2 | 0.38 | 0.26 | Upgrade |
EBIT | 14.75 | 3.61 | 0.24 | 1.58 | 0.62 | Upgrade |
EBIT Margin | 26.18% | 14.19% | 1.46% | 9.29% | 4.00% | Upgrade |
Effective Tax Rate | - | 6.55% | - | 22.41% | 71.56% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.